Search Results - "Pasek, Mildred"

Rituximab for steroid-refractory chronic graft-versus-host disease by Cutler, Corey, Miklos, David, Kim, Haesook T., Treister, Nathaniel, Woo, Sook-Bin, Bienfang, Don, Klickstein, Lloyd B., Levin, Jesse, Miller, Katherine, Reynolds, Carol, Macdonell, Rebecca, Pasek, Mildred, Lee, Stephanie J., Ho, Vincent, Soiffer, Robert, Antin, Joseph H., Ritz, Jerome, Alyea, Edwin

“…B cells may be implicated in the pathophysiology of chronic graft-versus-host disease (GVHD), as evidenced by antibody production against sex-mismatched, Y…”
Get full text

Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation by Ho, Vincent T, Vanneman, Matthew, Kim, Haesook, Sasada, Tetsuro, Kang, Yoon Joong, Pasek, Mildred, Cutler, Corey, Koreth, John, Alyea, Edwin, Sarantopoulos, Stefanie, Antin, Joseph H, Ritz, Jerome, Canning, Christine, Kutok, Jeffery, Mihm, Martin C, Dranoff, Glenn, Soiffer, Robert

“…Through an immune-mediated graft-versus-leukemia effect, allogeneic hematopoietic stem cell transplantation (HSCT) affords durable clinical benefits for many…”
Get full text

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation by Bashey, Asad, Medina, Bridget, Corringham, Sue, Pasek, Mildred, Carrier, Ewa, Vrooman, Linda, Lowy, Israel, Solomon, Scott R., Morris, Lawrence E., Holland, H. Kent, Mason, James R., Alyea, Edwin P., Soiffer, Robert J., Ball, Edward D.

“…Relapse of malignancy after allogeneic hematopoietic cell transplantation (allo-HCT) remains a therapeutic challenge. Blockade of the CTLA4 molecule can…”
Get full text

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells by Burkhardt, Ute E, Hainz, Ursula, Stevenson, Kristen, Goldstein, Natalie R, Pasek, Mildred, Naito, Masayasu, Wu, Di, Ho, Vincent T, Alonso, Anselmo, Hammond, Naa Norkor, Wong, Jessica, Sievers, Quinlan L, Brusic, Ana, McDonough, Sean M, Zeng, Wanyong, Perrin, Ann, Brown, Jennifer R, Canning, Christine M, Koreth, John, Cutler, Corey, Armand, Philippe, Neuberg, Donna, Lee, Jeng-Shin, Antin, Joseph H, Mulligan, Richard C, Sasada, Tetsuro, Ritz, Jerome, Soiffer, Robert J, Dranoff, Glenn, Alyea, Edwin P, Wu, Catherine J

“…Patients with advanced hematologic malignancies remain at risk for relapse following reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell…”
Get full text

Autologous Whole Tumor Cell Vaccination Early After Allogeneic Stem Cell Transplantation Elicits Anti-Tumor T Cell Responses in Patients with Advanced Chronic Lymphocytic Leukemia (CLL) by Burkhardt, Ute E., Hainz, Ursula, Stevenson, Kristen E., Wu, Di, Ho, Vincent T., Goldstein, Natalie R., Pasek, Mildred, Brown, Jennifer R., Canning, Christine M, Koreth, John, Cutler, Corey, Armand, Philippe, Neuberg, Donna S., Antin, Joseph H., Sasada, Tetsuro, Ritz, Jerome, Dranoff, Glenn, Soiffer, Robert J., Alyea, Edwin P, Wu, Catherine J.

“…Abstract 1892▪▪This icon denotes a clinically relevant abstract Patients with advanced hematological malignancies remain at high risk for eventual disease…”
Get full text

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies by Ho, Vincent, Dranoff, Glenn, Kim, Haesook, Vanneman, Matthew, Pasek, Mildred, Cutler, Corey, Koreth, John, Alyea, Edwin, Antin, Joseph H, Jerome, Ritz, Soiffer, Robert J

“…Studies have shown that leukemia specific donor immune responses can be elicited by cancer vaccination after allogeneic SCT. Given the likelihood of disease…”
Get full text

GM-CSF Secreting Leukemia Cell Vaccinations after Allogeneic Reduced-Intensity Peripheral Blood Stem Cell Transplantation (SCT) for Advanced Myelodysplastic Syndrome (MDS) or Refractory Acute Myeloid Leukemia (AML) by Ho, Vincent, Dranoff, Glenn, Kim, Haesook, Pasek, Mildred, Cutler, Corey, Alyea, Edwin, Koreth, John, Antin, Joseph H., Soiffer, Robert J.

“…Disease relapse is a frequent cause of treatment failure in patients undergoing reduced intensity allogeneic stem cell transplantation for advanced MDS and…”
Get full text

Clinical Trial of Therapeutic Blockade of CTLA4 with Ipilimumab in Patients with Relapse of Malignancy Following Allogeneic Hematopoietic Transplantation by Bashey, Asad, Medina, Bridget, Corringham, Sue, Pasek, Mildred, Carrier, Ewa, Vrooman, Linda, Streicher, Howard, Lowy, Israel, Solomon, Scott R., Morris, Lawrence E., Holland, Kent, Mason, James R., Soiffer, Robert J., Ball, Edward D.

“…Relapse/progression of malignancy (RM) is an important cause of treatment failure and death following allogeneic hematopoietic stem cell transplantation…”
Get full text

Phase I Study of Ipilimumab (Neutralizing Monoclonal Anti-CTLA4 Antibody) To Treat Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation: Evidence of Tumor Regression without Induction of GVHD by Bashey, Asad, Medina, Bridget, Corringham, Sue, Pasek, Mildred, Carrier, Ewa, Streicher, Howard, Lowy, Israel, Mason, James R., Soiffer, Robert J., Ball, Edward D.

“…Failure of adoptive cellular immunotherapy is an important cause of relapse of malignancy (RM) and death following allogeneic hematopoietic stem cell…”
Get full text

Phase I Study of a Neutralizing Monoclonal Anti-CTLA4 Antibody (MDX-010) in Patients with Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation by Bashey, Asad, Medina, Bridget, Corringham, Sue, Pasek, Mildred, Carrier, Ewa, Streicher, Howard, Lowy, Israel, Mason, James, Soiffer, Robert J., Ball, Edward D.

“…Relapse of malignancy is an important cause of treatment failure after allogeneic hematopoietic stem cell transplantation (allo-HCT). Malignant cells may evade…”
Get full text

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis by Cutler, Corey, Miklos, David, Lee, Stephanie J., Woo, Sook-Bin, Treister, Nathaniel, Bienfang, Don, Klickstein, Lloyd, Levin, Jesse, Miller, Katherine H., Reynolds, Carol, Pasek, Mildred, Ho, Vincent, Ritz, Jerome, Antin, Joseph H., Soiffer, Robert, Alyea, Edwin

“…The mechanism of tissue injury in chronic GVHD (cGVHD) is unknown, but donor-derived T cells are thought to be the primary effectors. We demonstrated that…”
Get full text